AKAOQ Gross Margin

The Gross Margin of Achaogen Inc (AKAOQ) is 99.64%.

Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.

AKAOQ Gross Margin - Historical Value

Date	Value
2018-12-31	99.64%

AKAOQ Gross Margin - Peers Comparison

Ticker	Name	Value
DNAG	DNAPrint Genomics Inc	30.99%
ISCO	International Stem Cell Corp	58.57%
BLCM	Bellicum Pharmaceuticals Inc	60.71%
CAPS	Capstone Holding Corp	84.75%
CXBS	Corix Bioscience Inc	7775.20%
ENDV	Endonovo Therapeutics Inc	92.62%
XSNX	NovAccess Global Inc	34.03%
BGES	Bio-Bridge Science Inc	2.02%
USRM	US Stem Cell Inc	71.03%
BIEI	Premier Graphene Inc	9.94%
MBCI	MabCure Inc	7775.20%
PANC	Panacos Pharmaceuticals Inc	100.00%
PROT	Stromacel Inc	101.96%
HXBM	Helix BioMedix Inc	36.82%
MBI.H.V	Many Bright Ideas Technologies Inc	7775.20%
NOHO	Novation Holdings Inc	76.90%
NNBP	Nanobac Pharmaceuticals Inc	16.67%
ADYX	Adynxx Inc	22.38%
IBT.V	IBEX Technologies Inc	69.41%
MPH.V	Medicure Inc	59.75%
MRPI	Mera Pharmaceuticals Inc	94.63%
KNE.V	Kane Biotech Inc	73.48%
WAVE.V	Waverley Pharma Inc	19.36%
ROSGQ	Rosetta Genomics Ltd	19.44%
NSTM	Novelstem International Corp	13.90%
PLPL	Plandai Biotechnology Inc	-215.99%
PPCB	Propanc Biopharma Inc	7775.20%
PPMD	Protide Pharmaceuticals Inc	72.02%